2024年6月7日 · Graft-versus-host disease (GVHD) is a systemic disorder occurring when immune cells from transplanted tissue recognize the recipient's body as foreign and attack its cells. In …

The 2005 National Institutes of Health (NIH) Consensus Conference proposed new criteria for diagnosing and scoring the severity of chronic graft-versus-host disease (GVHD). The 2014 …

Several large studies have shown potent GVT effects associated with the presence of chronic GVHD by NIH criteria and an increased risk of recurrent or progressive malignancy in patients …

2017年11月22日 · According to the 2014 NIH consensus, the broad category of acute GvHD includes classic acute GvHD (maculopapular erythematous rash, gastrointestinal symptoms or …

Chronic graft-versus-host disease (GVHD) is the leading cause of late morbidity and nonrelapse mortality after allogeneic hematopoietic cell transplantation (HCT). Treatment of chronic GVHD …

The 2005 National Institute of Health (NIH) Consensus Conference outlined histopathological diagnostic criteria for the major organ systems affected by both acute and chronic graft-versus …

This consensus document is intended to serve 3 functions. First, it standardizes the criteria for diagnosis of chronic graft-versus-host disease (GVHD). Second, it proposes a new clinical …

2009年7月7日 · In this analysis, NIH chronic GVHD was associated with a somewhat lower risk of recurrent malignancy (hazard ratio [HR], 0.74; 95% CI, 0.5-1.0; P = .07) and a lower rate of …

The 2005 National Institutes of Health (NIH) Consensus Conference proposed new criteria for diagnosing and scoring the severity of chronic GVHD. The 2014 NIH consensus maintains the …

2023年8月25日 · Chronic graft-versus-host disease (cGvHD) remains a prominent barrier to allogeneic hematopoietic stem cell transplantion as the leading cause of nonrelapse mortality …